Work

Biomarker analysis in a phase III study of pemetrexed–carboplatin versus etoposide–carboplatin in chemonaive patients with extensive-stage small-cell lung cancer

Year: 2011

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdr563

Authors: E.F. Smit, M.A. Socinski, B.P. Mullaney, S.P. Myrand, G.V. Scagliotti, P. Lorigan, M. Reck, T. Ciuleanu, J. von Pawel, N.A. Karaseva, A. Szczesna, D. Ohannesian, E. Powell, R.R. Hozak, S. Hong, S.C. Guba, N. Thatcher

Institutions: Amsterdam UMC Location Vrije Universiteit Amsterdam, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Eli Lilly (United States), University of Turin, The Christie Hospital, LungenClinic Grosshansdorf, Institute of Oncology Prof. Dr. Ion Chiricuta, Asklepios Fachkliniken München-Gauting

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2146583854

FWCI: 2.227

Cites: 39

Cited by: 29

Related to: 10